Molecularly Imprinted Polymer SPE- Acid NSAIDs from Muscle

By: Dr. Anja Siewing, Reporter US, Volume 29 Number 1

Introduction

The determination of acidic pharmaceuticals, such as nonsteroidal anti-inflammatory drugs (NSAIDs), at low levels in muscle tissue requires highly selective and sensitive analytical procedures. Final analysis by LC-MS-MS requires clean samples with minimal matrix effects; therefore, the removal of matrix components during sample preparation is critical for analysis. Here we describe a very simple method of concentrating and cleaning up NSAIDs from tissue using SupelMIP (molecularly imprinted polymer) phases.

MIPs are highly cross-linked, polymer-based, molecular recognition elements, which are capable of binding one target, one compound, or a class of structurally related target compounds, with high selectivity. The selectivity is introduced during MIP synthesis, in which a template molecule designed to mimic the analyte guides the formation of specific cavities, or imprints, that are sterically and chemically complementary to the target analytes.

Most of NSAID compounds have acidic functionality. The following subgroups can be recognized among NSAIDs and they include arylpropionic acid derivatives (Carprofen, Vedaprofen), oxicam derivatives (Meloxicam), nicotinic acid derivatives (Flunixin), and anthranilic acid derivatives (Diclofenac, Tolfenamic acid). Acidic NSAIDs are characterized by their ability to suppress the inflammatory process and associated symptoms such as pain, swelling, redness, and loss of function.

NSAIDs are widely used in veterinary medicine in the treatment of food-producing animals. Although they have short half-lives, these veterinary drugs and their metabolites may leave residues in edible tissue, which could have direct toxic effects on the consumers. In order to avoid risks, a strict legislative framework controls the use of these drugs, with the aim of minimizing the risk to human health. The European Union (EU) constituted maximum residue limits (MRLs) for numerous substances, which are administered for food-producing animals (Council Regulation No. 37/2010), to ensure human food safety.1 The acidic NSAIDs are a group of substances, for which maximum residue limits (MRL) have been set. The tolerance value in poultry muscle tissue (the national agreed value for these specific matrixes) for all NSAIDs analytes in the present work is 50 μg/kg.

The method presented here was sensitive and selective enough to detect these compounds below the tolerance level. The described method was fully validated according to the European Commission Decision 2002/657/EC2-4 for the analysis of veterinary drug residues.

Materials and Methods

The extraction procedure was adopted from R.J.B. Peters et al.5 Five grams of muscle tissue were weighed into 25 mL centrifuge tubes; internal standards and analytes were added to the samples. Four mL ammonium acetate buffer (10 mM, pH 5) and 6 mL acetonitrile were added. The mixture was shaken well by hand for 30 seconds, followed by a pH adjustment between pH value 4 and 5 with formic acid. The sample was shaken for 20 min, and then centrifuged for 5 min (3000 g at 20°C) to separate the phases.

10 mL of the supernatant were decanted into a clean, 50 mL centrifuge tube and diluted with 5 mL of 10 mM ammonium acetate buffer. The pH value of the samples (pH 3) was checked before proceeding to the solid phase extraction stage.6

The next step was the solid phase extraction (SPE) with SupelMIP®. All of the wash and elution steps were done according to the SupelMIP extraction protocol for NSAIDs. The SPE method is presented in Table 1.

Table 1. SPE Extraction Conditions

Condition:
1 mL acetonitrile, 1 mL methanol
  1 mL pH 3 ammonium formate buffer
Load: 5 mL sample
Wash: 1. 1 mL water – vacuum was applied for 5 min
  2. 1 mL acetonitrile:water (40:60) – vacuum was applied for 2 min
  3. 1 mL toluene:heptane (40:60) vacuum was applied for 4 min
Elution: 1 mL 1% acetic acid in 20:80 acetone:methanol

The eluate was evaporated to dryness under nitrogen at 50 °C and reconstituted in 150 μL acetonitrile: methanol (9:1 v/v) with 0.1% formic acid. The extracts were filtered through a 0.2 μm filter and transferred into HPLC vials. The LC-MS conditions are presented in Figure 1.

Results and Discussion

We looked for a sample preparation method that would allow low NSAIDs detection limits, and provide easy cleanup from poultry muscle tissue. The first liquid-liquid extraction step was using acetonitrile: water efficiently precipitated the proteins. If that extraction step is not performed, the samples could have formed a gel-like consistency in the presence of water, and would have been hard to handle. Experiments were also carried out to compare the efficiency of protein separation by liquid-liquid extraction with that by hydrolysis using protease. The use of protease resulted in a loss of analyte, which was probably due to less efficient protein removal.

 

column: Ascentis Express® C18, 15 cm x 3.0 mm I.D., 2,7 μm
det.: MS-MS, negative ESI with two MRM transitions, curtain gas
  40.00 psi; ion spray voltage 4500 V; temperature 400° C;
  gas 1 40 psi; gas 2 70 psi;
flow rate: 400 μL/min
injection: 10 μL
mobile phase: gradient (A) water: acetonitrile (90:10) with 1mM acetic acid;
  (B) acetonitrile; 90% A to 10% A in 23 min, re-equilibration at
  90% A for 12 min.
temp.: 40 °C
   
1. Meloxicam (red, blue, grey - IS)
2. Flunixin (green, red, blue – IS)
3. Carprofen (red, green, blue - IS)
4. Diclofenac (red, blue, black - IS)
5. Tolfenamic acid (blue, green, red - IS)
6. Vedaprofen (red, green, blue –IS)

 

Extracted Ion Chromatogram of a Muscle Matrix Sample Spike

Figure 1. Extracted Ion Chromatogram of a Muscle Matrix Sample Spike with Six Standard Analytes (48 μg/mL) and the Internal Standards (80 μg/mL) Mix of NSAIDs

During method validation the sample preparation procedures were applied to 16 poultry muscle samples. The samples were spiked at the following concentration levels:

Meloxicam, Flunixin, Carprofen, Diclofenac, and Tolfenamic acid:
Level 1: 16 μg/kg, Level 2: 32 μg/kg, Level 3: 48 μg/kg, Level 4: 64 μg/kg
Vedaprofen: Level 1: 30 μg/kg; Level 2: 60 μg/kg; Level 3: 90 μg/kg, Level 4: 120 μg/kg

Quantification was done by using standard matrix-matched calibration curves. On the basis of these results, we calculated decision limit CCα, detection capability CCβ, and recovery as well as the within-laboratory reproducibility. Table 2 shows the calculated validation results for poultry muscle.

The recovery values for each compound at the level of interest are above 90%, thus meeting the requirements of Commission Decision 2002/657/EC. The ion suppression due to matrix effects was low. Our calculated decision limits CCα for the level of interest are below the required value.

Table 2. Summary of the Calculated Validation Results for Poultry Muscle Samples

 

Substance CCα [μg/ kg] CCβ [μg/ kg] RSD [%] Recovery [%]
Carprofen 19.7 22.4 9.3 96.1
Vedaprofen 40.1 47.3 13.9 92.3
Meloxicam 19.9 22.8 9.5 96.8
Flunixin 20.3 23.4 10.2 97.4
Diclofenac 20.8 24.1 11.0 103.1
Tolfenamic acid 20.6 23.8 11.3 94.1

Conclusions

In this article we described a new, successfully developed and validated, LC-MS-MS method allowing the extraction of NSAIDs from poultry muscle tissue using MIP SPE. SupelMIP offered the selectivity necessary to achieve sensitivity; detection limits and quantitation in tissue at the low concentration level that was below the maximum residue limits. Furthermore, cleaner extracts were obtained with this rapid extraction technique when analyzing difficult and dirty sample matrices. Running cleaner samples resulted in less contamination to LC-MS instrument, and less maintenance was required. The ruggedness of the SupelMIP SPE was proven by a systematic variation of the validation factors on two levels. Thus, the extraction method is fit for purpose and can be applied in routine analysis.

 

Materials

     

References

  1. European Commission, Council regulation 37/2010/EEC, Off. J. Eur. Commun., L 15 (2010) 1
  2. Commission Decision (2002/657/EC) of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and interpretation of results, Off J. Eur. Commun., L221 (2002) 8
  3. Document SANCO SANCO/2004/2726 rev 4 (2008), Guidelines for the implementation of decision 2002/657/EC
  4. Council Directive 96/23/EC of April 1996 on measures to monitor certain
    substances and residues thereof in live animals and animal products (1996), Off J. Eur. Commun L125:10-32
  5. R.J.B.Peters et al. J.Chromat. A 1216 (2009) 8206-8216
  6. S. Zorita et al. Analytica Chimica Acta, Volume 626, Issue 2, 26 September 2008, Pages 147-154

 

Related Links